Seeking Alpha

Alder files for $115M IPO

  • Alder Biopharmaceuticals has filed to raise up to $115M in an IPO on Nasdaq.
  • The company develops anti-bodies for treating a range of conditions, and its pipeline includes Clazakizumab, which the the company is developing with Bristol-Myers Squipp for Rheumatoid Arthritis, and ALD403 for migraines.
  • Alder posted losses of $20.6M in 2013.
  • The company intends to trade under the ticker symbol ALDR.
  • ETF: IPO
  • S-1
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector